Dissecting Inflammatory Complications in Critically Injured Patients by Within-Patient Gene Expression Changes: A Longitudinal Clinical Genomics Study

English version České info

Background:
Trauma is the number one killer of individuals 1–44 y of age in the United States. The prognosis and treatment of inflammatory complications in critically injured patients continue to be challenging, with a history of failed clinical trials and poorly understood biology. New approaches are therefore needed to improve our ability to diagnose and treat this clinical condition.

Methods and Findings:
We conducted a large-scale study on 168 blunt-force trauma patients over 28 d, measuring ∼400 clinical variables and longitudinally profiling leukocyte gene expression with ∼800 microarrays. Marshall MOF (multiple organ failure) clinical score trajectories were first utilized to organize the patients into five categories of increasingly poor outcomes. We then developed an analysis framework modeling early within-patient expression changes to produce a robust characterization of the genomic response to trauma. A quarter of the genome shows early expression changes associated with longer-term post-injury complications, captured by at least five dynamic co-expression modules of functionally related genes. In particular, early down-regulation of MHC-class II genes and up-regulation of p38 MAPK signaling pathway were found to strongly associate with longer-term post-injury complications, providing discrimination among patient outcomes from expression changes during the 40–80 h window post-injury.

Conclusions:
The genomic characterization provided here substantially expands the scope by which the molecular response to trauma may be characterized and understood. These results may be instrumental in furthering our understanding of the disease process and identifying potential targets for therapeutic intervention. Additionally, the quantitative approach we have introduced is potentially applicable to future genomics studies of rapidly progressing clinical conditions.

Trial Registration: ClinicalTrials.gov NCT00257231

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Dissecting Inflammatory Complications in Critically Injured Patients by Within-Patient Gene Expression Changes: A Longitudinal Clinical Genomics Study. PLoS Med 8(9): e32767. doi:10.1371/journal.pmed.1001093
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001093

Souhrn

Zdroje

1. SasserSMHuntRCSulliventEEWaldMMMitchkoJ 2009 Guidelines for field triage of injured patients. Recommendations of the National Expert Panel on Field Triage. MMWR Recomm Rep 58 1 35

2. SoniA 2009 The five most costly conditions, 1996 and 2006: Estimates for the U.S. civilian noninstitutionalized population. Statistical Brief Rockville Agency for Healthcare Research and Quality 1 5

3. PedenMMcGeeKKrugE 2002 Injury: A leading cause of the global burden of disease, 2000. Geneva World Health Organization

4. HofmanKPrimackAKeuschGHrynkowS 2005 Addressing the growing burden of trauma and injury in low- and middle-income countries. Am J Public Health 95 13 17

5. DeCampMMDemlingRH 1988 Posttraumatic multisystem organ failure. J Am Med Assoc 260 530 534

6. MarshallJCVincentJLSibbaldWJ 1995 Clinical Trials for the Treatment of Sepsis. VincentJLSibbaldWJ Berlin Springer-Verlag 122 138

7. DewarDMooreFAMooreEEBaloghZ 2009 Postinjury multiple organ failure. Injury 40 912 918

8. OpalSM 2003 Clinical trial design and outcomes in patients with severe sepsis. Shock 20 295 302

9. BaueAE 1997 Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? Arch Surg 132 703 707

10. CobbJPMindrinosMNMiller-GrazianoCCalvanoSEBakerHV 2005 Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A 102 4801 4806

11. CalvanoSEXiaoWRichardsDRFelcianoRMBakerHV 2005 A network-based analysis of systemic inflammation in humans. Nature 437 1032 1037

12. JohnsonSBLissauerMBochicchioGVMooreRCrossAS 2007 Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 245 611 621

13. CollinsF 2010 Has the revolution arrived? Nature 464 674 675

14. FeeroWGGuttmacherAECollinsFS 2010 Genomic Medicine: Genomic Medicine – An Updated Primer. N Engl J Med 362 2001 2011

15. FrantzS 2005 An array of problems. Nat Rev Drug Discov 4 362 363

16. PotterJD 2001 At the interfaces of epidemiology, genetics and genomics. Nat Rev Genet 2 142 147

17. MarshallJCCookDJChristouNVBernardGRSprungCL 1995 Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23 1638 1652

18. StoreyJDTibshiraniR 2003 Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100 9440 9445

19. JolliffeIT 2002 Principal Component Analysis NY Springer

20. IoannidisJPA 2005 Microarrays and molecular research: Noise discovery? Lancet 365 454 455

21. MichielsSKoscielnySHillC 2005 Prediction of cancer outcome with microarrays: A multiple random validation strategy. Lancet 365 488 492

22. DennisGShermanBTHosackDAYangJGaoW 2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 P3

23. HuangDWShermanBTTanQCollinsJRAlvordWG 2007 The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8 R183

24. HasselgrenPOHubbardWJChaudryIH 2007 Metabolic and inflammatory responses to trauma and infection. FischerJE Mastery of Surgery. Fifth ed Philadelphia Lippincott Williams & Wilkins 2 23

25. DareAJPhillipsARHickeyAJMittalALovedayB 2009 A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radic Biol Med 47 1517 1525

26. WullaertAHeyninckKJanssensSBeyaertR 2006 Ubiquitin: tool and target for intracellular NF-kappa B inhibitors. Trends Immunol 27 533 540

27. HanJLeeJDBibbsLUlevitchRJ 1994 A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 808 811

28. RosengartMRNathensABArbabiSNeffMJGarciaI 2003 Mitogen-activated protein kinases in the intensive care unit: Prognostic potential. Ann Surg 237 94 100

29. ChainBMKayePMShawMA 1988 The biochemistry and cell biology of antigen processing. Immunol Rev 106 33 58

30. CresswellP 1987 Antigen recognition by T lymphocytes. Immunol Today 8 67 69

31. KyriakisJMAvruchJ 2001 Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81 807 869

32. DongCDavisRJFlavellRA 2002 MAP kinases in the immune response. Annu Rev Immunol 20 55 72

33. ZhangQRaoofMChenYSumiYSursalT 2010 Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464 104-U115

34. LiuSFMalikAB 2006 NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290 L622 L645

35. BohrerHQiuFZimmermanTZhangYMJllmerT 1997 Role of NF kappa B in the mortality of sepsis. J Clin Invest 100 972 985

36. AhnACTewariMPoonCSPhillipsRS 2006 The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med 3 e208 doi:10.1371/journal.pmed.0030208

37. DitschkowskiMKreuzfelderERebmannVFerencikSMajetschakM 1999 HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 229 246 254

38. MonneretGLepapeAVoirinNBohéJVenetF 2006 Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32 1175 1183

39. SpruijtNEVisserTLeenenLPH 2010 A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit Care 14 R150

40. BochicchioGVNapolitanoLMJoshiMKnorrKTracyJK 2002 Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma 53 245 251

41. HooverLBochicchioGVNapolitanoLMJoshiMBochicchioK 2006 Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma 61 310 316

42. TsukamotoTChanthaphavongRSPapeH-C 2010 Current theories on the pathophysiology of multiple organ failure after trauma. Injury 41 21 26

43. MunfordRSPuginJ 2001 Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Resp Crit Care 163 316 321

44. ReddyRCChenGHTekchandaniPKStandifordTJ 2001 Sepsis-induced immunosuppression - From bad to worse. Immunol Res 24 273 287

45. MockCNDriesDJJurkovichGJMaierRV 1996 Assessment of two clinical trials: interferon-gamma therapy in severe injury. Shock 5 235 240